SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

NEW YORK, July 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. [Click here for information about joining the class action] On this news, PTC's stock price fell $4.08 per share, or 11.77%, to close at $30.58 per share on June 28, 2024. Attorney advertising. Prior results do not guarantee similar outcomes. ...